Company Watch

Serum Institute launches Td-Vac for adults

Our News Bureau - Mumbai

Serum Institute of India, announced the launch of Td-Vac, a Tetanus and Diphtheria vaccine for combating the fatal diseases in adolescents and adults.

The Td vaccine is different from the normal DT (dual antigen) vaccine used in children. This new vaccine will replace the existing usage of TT (Tetanus) vaccine, which is normally given post-injury. According to Dr Cyrus Poonawalla, Chairman of Serum Institute of India, "Serum Institute has always looked at launching international standard life saving vaccines in the Indian market. Health authorities in the Western countries advise the use of Td (Tetanus and Diphtheria) vaccine instead of the TT (Tetanus) vaccine. We are offering the Indian, the benefit of two vaccines in one, and which is a norm in developed countries." Td-Vac, priced at Rs 7.50, provides safety against Diphtheria and Tetanus (Td), while the Tetanus (TT) vaccine is priced as Rs 6.50.